“…Public suspicion of the private sector and genetically modified (GM) technology was cited as a major barrier to building trust between the PPP projects and the public, and, occasionally, between the PPP projects and the regulatory bodies of the government. This challenge was brought up by stakeholders in several case studies, including those conducted in Burkina Faso [3], Nigeria [6] and Kenya [7]. Stakeholders mentioned that the public questions the motive behind the private sector's involvement in agbiotech projects in Africa; the public suspects that the private sector is being driven solely by the profit motive.…”